Rani Therapeutics: ‘We’ve Tested A Dozen Molecules, All Of Them Have Worked’

CEO Talat Imran: ‘I Think We Get An Inbound Partner Interest Every Week At This Point’

Talat Imran, Rani Therapeutics
'We’re in great shape, we don’t have to raise money right now' • Source: Rani Therapeutics

More from Biosimilars

More from Products